Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of ALLN-177 to reduce urinary oxalate
excretion in patients with recurring kidney stones and enteric or idiopathic hyperoxaluria.